Skip to main content

Table 3 Univariate analysis of overall survival in colorectal adenocarcinoma

From: The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease

Variables

 

HR (95% CI)

P-value

Gender

  

0.004

 

Female

1.0

 
 

Male

1.349 (1.098, 1.656)

 

Age, years

  

0.049

 

< 65

1.0

 
 

≧ 65

1.217 (1.001, 1.480)

 

Location

  

0.049

 

Colon

1.0

 
 

Rectum

1.212 (1.000, 1.468)

 

Size, cm

  

< 0.001

 

< 5

1.0

 
 

≧ 5m

2.432 (2.001, 2.955)

 

Preoperative serum CEA, ng/ml

 

< 0.001

 

< 5.0

1.0

 
 

≧ 5.0

3.223 (2.654, 3.915)

 

Depth of invasiona

 

< 0.001

 

T1, T2

1.0

 
 

T3, T4

6.122 (4.311, 8.694)

 

Lymph node metastasisa

 

< 0.001

 

N0

1.0

 
 

N1, N2

4.527 (3.972, 5.122)

 

Distant metastasisa

 

< 0.001

 

M0

1.0

 
 

M1

8.133 (6.697, 9.877)

 

Operating facility

 

< 0.001

 

Center A

1.0

 
 

Center B

2.365 (1.943, 2.878)

 

Histological type

 

< 0.001

 

NMA

1.0

 
 

MA

2.614 (1.905, 3.585)

 
  1. aStaging of tumor (T), nodes (N), and metastases (M) [24]; HR, hazard ratio; CI, confidence interval; NMA, non-mucinous adenocarcinoma; MA, mucinous adenocarcinoma.